Press

Press

News room

How one university system plans to send home thousands of students for Thanksgiving break

November 2020

ABC News

Study confirms spit testing may help doctors diagnose concussions

November 2020

Health News Digest

Siena College sends wastewater samples to lab for early detection of COVID-19

October 2020

News 10 Albany

In the fight against COVID, colleges look to wastewater

October 2020

WHAM

OraSure's OMNIgene® ORAL Collection Device Receives FDA Emergency Use Authorization for SARS CoV-2

October 2020

GlobeNewswire

Upstate Medical Gets FDA Approval for Wider Use of its Saliva Swab COVID-19 Test

October 2020

CNY Business Journal

Coronavirus 'smoke detector' launched in Syracuse put brakes on SUNY Oneonta outbreak

September 2020

Syracuse.com

OraSure's ORAcollect RNA Device Included in EUA Granted to Quadrant Biosciences Inc. for COVID-19 Test

September 2020

Biospace

Governor Cuomo and Chancellor Malatras Announce FDA Approval for COVID-19 Saliva Swab Test

September 2020

NYS Governor’s Office

SUNY may implement biweekly testing to stem campus COVID-19 outbreaks

September 2020

New York Post

Saliva test for COVID-19 approved by NY Dept. of Health

September 2020

WHAM

Governor Cuomo announces new testing initiatives to improve COVID-19 detection & control across New York State

August 2020

New York State News

University Scientists Selected to Implement COVID-19 Early Warning System in Upstate New York

August 2020

SUNY ESF

New York State partners with Arcadis to pilot early detection of COVID-19 in wastewater

August 2020

GlobeNewswire

Groundbreaking autism test developed in CNY would diagnose children through saliva

December 2019

CNY Central

Saliva test for autism hits market; Syracuse research could lead to faster help for kids

December 2019

Syracuse

Microbes in Saliva May Offer Way of Detecting and Understanding Early Stages of Parkinson’s, Study Says

July 2019

Parkinsons News Today

Quadrant Biosciences Recognized as New York Technology Business of the Year

May 2019

Market Watch

Study finds correlation between specific epigenetic molecules and autism traits

April 2019

BioSpace

Samsung Spotlights New Digital Health Solutions at HIMSS 2019

February 2019

Samsung Newsroom U.S.

Biomarker panel can detect autism earlier in children using saliva

November 2018

UPI

Saliva-Based RNA Biomarker Test Could Serve as Early Diagnostic Tool for Autism

November 2018

Genetic Engineering & Biotechnology News

Saliva Test Distinguishes Children On Autism Spectrum From Non-Autistic Peers

November 2018

Science Blog

Saliva-based RNA panel distinguishes children on autism spectrum from non-autistic peers

November 2018

EurekAlert

Quadrant Biosciences Teams up With Autism Speaks to Provide Support to Families and Healthcare Providers on the Path from Autism Diagnosis to Early Intervention

November 2018

Business Wire

Oral microbial activity may help identify autism in children

August 2018

Healio

Circadian Molecules in Saliva Different in Kids with Sleep Disorders

August 2018

Sleep Review

The Scoop: Tracking MicroRNAs to Study Brain Dysfunction

July 2018

Genetic Engineering & Biotechnology News

THE FATE OF FOOTBALL: Spitting image — new test helps identify concussions

May 2018

NY Daily News

DNA Genotek’s top 10 list for 2017

January 2018

DNA GenoTek

Saliva Test Could Diagnose Concussion

November 2017

WebMD

Spit test may diagnose, predict duration of concussion in kids

November 2017

CNN

Could saliva help diagnose concussions?

May 2017

WRVO

Researchers Discover Novel BioMarker in Saliva that Identifies Concussion in Children and Predicts Length of Recovery

May 2017

Huffington Post

Spit Test May Reveal The Severity Of A Child's Concussion

May 2017

NPR

Press releases

Saliva testing may help doctors diagnose concussions

November 2020

Doctors may soon be able to more accurately diagnose concussions by measuring the number of certain molecules in a person’s saliva.

Saliva may hold key to concussion diagnosis and managment

October 2020

A simple saliva swab may hold the key to diagnosing and managing mild traumatic brain injury (i.e., concussions), according to a study recently published in the journal Clinical and Translational Medicine.

Quadrant Biosciences Receives FDA Emergency Authorization for New COVID-19 Saliva Test

September 2020

New test offers simple, easy to administer saliva swab for COVID-19 testing.

Quadrant Biosciences Wins $2.3M NIH Grant to Develop Saliva Test for Concussion

September 2020

Quadrant Biosciences said on Monday that it has received a $2.3 million grant from the National Institutes of Health to develop its saliva-based microRNA diagnostic test for concussions in children and adolescents.

Renowned autism researcher Dr. Thomas Frazier joins Quadrant Biosciences Clinical Advisory Board

June 2020

 Dr. Frazier will help guide research and clinical acceptance of the new Clarifi autism saliva test.

Quadrant Biosciences Receives CPT® Proprietary Laboratory Analyses Code from the American Medical Association

April 2020

Quadrant Biosciences Inc (Quadrant Biosciences) announced today that the American Medical Association (AMA) has issued a new CPT® Proprietary Laboratory Analyses (PLA) code for its Clarifi ASD™ autism saliva test.

Company That just Released World’s First Saliva Test for Autism Opens Up Investment Opportunity to the Public

March 2020

Quadrant Biosciences Inc, a leading developer of epigenetic diagnostic solutions, including the world’s first saliva test for autism, announced that it is now offering common shares of the company (at a price of $3/share, with a minimum investment of $300) through equity crowdfunding platform Wefunder.

Quadrant Biosciences Launches First Ever Epigenetic Saliva Test for Autism

December 2019

Quadrant Biosciences Inc., a developer of novel diagnostic solutions, announced the release of Clarifi ASD™, the first ever epigenetic test for autism spectrum disorder (ASD).

New Research shows link between Parkinson's disease and the microbiome

July 2019

A simple saliva swab may provide an accurate way of detecting Parkinson’s disease in its earliest stages, according to a study just published in the journal Plos One.

Quadrant Biosciences Recognized as New York Technology Business of the Year

May 2019

Quadrant Biosciences Inc. has been awarded the Technology Business of the Year by the New York State Small Business Development Center (SBDC).

Quadrant Biosciences Teams up With Autism Speaks to Provide Support to Families and Healthcare Providers on the Path from Autism Diagnosis to Early Intervention

November 2018

As part of its commitment to helping people with autism and their families and increasing early intervention through early diagnosis, Quadrant Biosciences announced today that they will support Autism Speaks’ mission with funding to expand delivery of reliable information, resources and support through the Autism Speaks Autism Response Team.

Quadrant Biosciences Partners with Leading Edge Genomic Testing Company Admera Health

August 2018

Quadrant Biosciences Inc., an emerging life science company based in Syracuse, New York, is pleased to announce its strategic partnership with Admera Health, an advanced molecular diagnostics company headquartered in South Plainfield, NJ.

Wall Street Veteran Peter Cohen joins Quadrant Biosciences Board of Directors

April 2018

Quadrant Biosciences Inc., a Syracuse, New York-based Life Science company, announced today that Wall Street veteran Peter Cohen will be joining its Board of Directors.

Motion Intelligence Inc. changes name to Quadrant Biosciences Inc. to Better Reflect Broader Business Focus

June 2017

Motion Intelligence Inc. announced that it has changed its company name to Quadrant Biosciences Inc. The Syracuse, New York-based neuroscience company is involved in the development of functional assessments and epigenetic diagnostic solutions for large-scale health issues.